For Canada’s life sciences sector, the stakes are even higher in the trade war with the U.S.—both livelihoods and lives are at risk.
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
The Patented Medicine Prices Review Board just needs to stop trying to push an agenda and go back to doing its job as an impartial regulator that implements clear and predictable rules.
